BioCell AI
Barcelona, Spain· Est.
An AI-driven biotech using machine learning to enhance diagnostics and develop targeted drug delivery systems.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $40M
AI Company Overview
An AI-driven biotech using machine learning to enhance diagnostics and develop targeted drug delivery systems.
OncologyNeurology
Technology Platform
A proprietary AI/ML platform that analyzes biological data to discover biomarkers and design optimized drug delivery systems for targeted therapies.
Funding History
1Total raised:$40M
Follow-on Offering$40M
Opportunities
Large potential in partnering with big pharma to reduce clinical failure rates and develop companion diagnostics.
Risk Factors
High dependency on data quality and successful validation of AI predictions in real-world clinical settings.
Competitive Landscape
Faces competition from numerous AI-driven drug discovery platforms like Exscientia and Recursion, but its integrated focus on diagnostics and delivery is a niche differentiator.